-
1
Impact analysis of expanded access to ketamine for treatment-resistant depression
Published 2025-05-01“…Becaris Publishing Limited…”
Article -
2
Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis
Published 2025-02-01“…Becaris Publishing Limited…”
Article -
3
Elranatamab versus physician’s choice of treatment in patients with triple-class exposed/refractory multiple myeloma: an updated matching-adjusted indirect comparison
Published 2025-04-01“…Becaris Publishing Limited…”
Article -
4
Matching-adjusted indirect comparison between garadacimab and lanadelumab for the long-term prophylactic treatment of patients with hereditary angioedema
Published 2025-07-01“…Becaris Publishing Limited…”
Article -
5
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 19
Published 2025-05-01“…Becaris Publishing Limited…”
Article -
6
Cost-per-remitter for esketamine nasal spray versus quetiapine for treatment-resistant depression
Published 2025-06-01“…Becaris Publishing Limited…”
Article -
7
Evaluation of reporting in time-driven activity-based costing studies on cardiovascular diseases: a scoping review
Published 2025-02-01“…Becaris Publishing Limited…”
Article -
8
Access in all areas? A round up of developments in market access and health technology assessment: part 7
Published 2025-04-01“…Becaris Publishing Limited…”
Article -
9
Time-limited reimbursement and Temporary Access Process for early access to oncology treatments in Canada: a perspective based on the epcoritamab experience
Published 2025-04-01“…Becaris Publishing Limited…”
Article -
10
Clinical and economic implications of focal dissection treatment following percutaneous transluminal angioplasty of the superficial femoral artery: an exploratory analysis based on...
Published 2024-12-01“…Becaris Publishing Limited…”
Article -
11
Characterization of medical device randomized controlled trials with adaptive designs
Published 2024-12-01“…Becaris Publishing Limited…”
Article -
12
Quality in qualitative evidence: new best practice principles from NICE’s real-world evidence framework
Published 2025-06-01“…Becaris Publishing Limited…”
Article -
13
Advancing the role of real-world evidence in comparative effectiveness research
Published 2024-10-01“…Becaris Publishing Limited…”
Article -
14
Clinical assessment of the potential use of a novel single-dose prefilled injection device for the administration of Acthar Gel in children: a narrative review
Published 2024-01-01“…Becaris Publishing Limited…”
Article -
15
Economic impact of reduced postoperative visits after inflatable penile prosthesis implantation
Published 2025-01-01“…Becaris Publishing Limited…”
Article -
16
Access in all areas? A round up of developments in market access and health technology assessment: part 8
Published 2025-01-01“…Becaris Publishing Limited…”
Article -
17
Single-use endoscopy for the evaluation of swallowing: a performance survey
Published 2025-06-01“…Becaris Publishing Limited…”
Article -
18
Long-term effectiveness and safety of ravulizumab in paroxysmal nocturnal hemoglobinuria: a plain language summary
Published 2025-07-01“…Becaris Publishing Limited…”
Article -
19
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 18
Published 2025-02-01“…Becaris Publishing Limited…”
Article -
20
Comparative safety of B/F/TAF versus other antiretroviral therapy regimens for treatment-naive people with HIV-1: a systematic literature review and network meta-analysis
Published 2025-05-01“…Becaris Publishing Limited…”
Article